Recent Material Events - Alexion Pharmaceuticals (ALXN)

Filing Date	Description
2008-11-12	Mr. Keiser will remain on Alexion’s Board of Directors at least through the expiration of his current term in 2009 and will be available to consult with management and the Board in the future. ...
2008-10-23	The attached press release contains both U.S. Generally Accepted Accounting Principles (“GAAP”) and non-GAAP financial measures. The non-GAAP financial measures exclude share-based compensation expenses. Reconciliations between non-GAAP and ...
2008-07-29	The attached press release contains both U.S. Generally Accepted Accounting Principles (“GAAP”) and non-GAAP financial measures. The non-GAAP financial measures exclude share-based compensation expenses. Reconciliations between non-GAAP and ...
2008-04-30	The attached press release contains both U.S. Generally Accepted Accounting Principles (“GAAP”) and non-GAAP financial measures. The non-GAAP financial measures exclude share-based compensation expenses. Reconciliations between non-GAAP and ...
2008-02-04	On January 31, 2008, SB2, Inc. filed a civil action against Alexion Pharmaceuticals, Inc. in the U.S. District Court for the Northern District of California. SB2, Inc. claims willful infringement by Alexion of SB2, Inc. patents. SB2, Inc. seeks, amon ...
2007-10-26	The attached press release contains both U.S. Generally Accepted Accounting Principles (“GAAP”) and non-GAAP financial measures. The non-GAAP financial measures exclude share-based compensation expenses. Reconciliations between non-GAAP and ...
2007-03-19	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.... ...
2007-02-15	The attached press release contains both GAAP and non-GAAP financial measures. The non-GAAP financial measures exclude share-based compensation expenses. Reconciliations between non-GAAP and GAAP financial measures are included in the press release s... ...
2006-12-15	On December 11, 2006, Alexion Pharmaceuticals, Inc. (the “Company”) notified its San Diego based subsidiary, Alexion Antibody Technologies, Inc. (“AAT”), that all activities and technologies at AAT will be transferred to the Compa... ...
2006-11-22	99.1 Press Release issued by Alexion Pharmaceuticals, Inc. on November 21, 2006. Signature... ...